• Mashup Score: 0

    Philadelphia-negative myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF), are hematologic malignancies characterized by the abnormal proliferation of blood cells in the bone marrow. MPNs cause significant morbidity in the form of burdensome symptoms, potentially fatal cardiovascular complications, progression to…

    Tweet Tweets with this article
    • There are more and better options to treat #MPNs than ever, and many potential new treatments in late-stage clinical trials. Read a treatment landscape summary HERE: https://t.co/e8FL9zWPOl #BCAM #ThisIsBloodCancer @RaajitRampal @GhaithAbuZeinah @MSKCancerCenter @WCMLeukemia https://t.co/Z08JCe9V26

  • Mashup Score: 3
    Letters to the Editors - 8 month(s) ago

    The LRF Advocacy Program provides volunteers with the tools necessary to garner support for public policies important to the lymphoma community

    Tweet Tweets with this article
    • With advances in research, the number of survivors is growing – and so is the need to improve care with legislation like the #ComprehensiveCancerSurvivorshipAct. Raise awareness by advocating for this critical legislation: https://t.co/EcIBQz5zu0 #BloodCancerAwarenessMonth #BCAM https://t.co/u3M087fpJA

  • Mashup Score: 0

    Sign up to ride, run, walk, or move your body during the National Blood Clot Awareness 100,000 Reasons Challenge.

    Tweet Tweets with this article
    • Two weeks until Blood Clot Awareness Month! Have you registered for our 100,000 Reasons Challenge yet? Join us as we ride, run or walk during March in honor of the 100,000 lives lost each year to blood clots. Sign up: https://t.co/xt92oM3eSc #bcam #stoptheclot #raiseawareness https://t.co/8D8p00NisJ

  • Mashup Score: 0

    Unfortunately the website is temporarily unavailable. We are working to fix the issue and it should be back online shortly. Please try visiting the ICR home page again in a few minutes. We apologise for an inconvenience this may cause. If you need to get in touch, you can still contact us. …

    Tweet Tweets with this article
    • 🔬💊NEWS: A new #BreastCancer test could detect women who are less likely to respond to a standard breast cancer treatment. The findings could potentially guide future treatment for women with ER+/HER2+ tumours: https://t.co/vrst6ddP6D #BCAM #BreastCancerAwarenessMonth https://t.co/5MHSMiwrv9

  • Mashup Score: 0

    In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.

    Tweet Tweets with this article
    • Can #AI Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital #Mammography? https://t.co/BimrWzQh2j @ACRRFS @ACRYPS @RadiologyACR @ARRS_Radiology @RSNA @JBI_SBI @BreastImaging @SBIRFS @RadiologyUSC @StanfordRad @OHSURadiology #radiology #BCAM #RadRes https://t.co/BzFT6cGRxq

  • Mashup Score: 0

    Learn about the latest breast cancer research topics here. See what questions are being asked to find better ways to prevent, detect & treat breast cancer.

    Tweet Tweets with this article
    • To end women's cancer, we need more research to find better ways to prevent, detect, & treat cancers like #breastcancer. This #BreastCancerAwarenessMonth, see what's new in breast cancer research from @americancancer: https://t.co/XxNl1xDeel #BCAM #MoveTheMessage #Move4Her https://t.co/jVH1H7T0uq